EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Automated Uniform Spheroid Generation Platform for High Throughput Drug Screening Process

Kelvin C C Pong iD, Yuen Sze Lai, Roy Chi Hang Wong iD, Alan Chun Kit Lee iD, Sam C T Chow, Jonathan C W Lam, Ho Pui Ho, Clarence T T Wong iD

Biosensors · 2024

DOI: 10.3390/bios14080392 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biosensors, 2024. Verfasst von Kelvin C C Pong und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, The Chinese University of Hong Kong, New Territories, Hong Kong, China. Hauptthemen laut MEDLINE: Spheroids, Cellular, High-Throughput Screening Assays. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hong Kong Polytechnic University, Hong Kong Polytechnic University Startup Fund for New Recruits.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Three-dimensional (3D) spheroid models are crucial for cancer research, offering more accurate insights into tumour biology and drug responses than traditional 2D cell cultures. However, inconsistent and low-throughput spheroid production has hindered their application in drug screening. Here, we present an automated high-throughput platform for a spheroid selection, fabrication, and sorting system (SFSS) to produce uniform gelatine-encapsulated spheroids (GESs) with high efficiency. SFSS integrates advanced imaging, analysis, photo-triggered fabrication, and microfluidic sorting to precisely control spheroid size, shape, and viability. Our data demonstrate that our SFSS can produce over 50 GESs with consistent size and circularity in 30 min with over 97% sorting accuracy while maintaining cell viability and structural integrity. We demonstrated that the GESs can be used for drug screening and potentially for various assays. Thus, the SFSS could significantly enhance the efficiency of generating uniform spheroids, facilitating their application in drug development to investigate complex biological systems and drug responses in a more physiologically relevant context.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spheroids, CellularHigh-Throughput Screening AssaysHumansDrug Evaluation, PreclinicalCell SurvivalDrug Screening Assays, AntitumorCell Line, TumorCell Culture Techniques

Stichwörter der Autor:innen

3D spheroidautomationdrug screeningmicrofluidic

Autor:innen und Institutionen

  • Department of Biomedical Engineering, The Chinese University of Hong Kong, New Territories, Hong Kong, China.
  • BioArchitec Group Limited, Hong Kong, China.
  • State Key Laboratory of Chemical Biology and Drug Discovery, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Kowloon, Hong Kong, China.

ORCID-Profile: Kelvin C C Pong, Roy Chi Hang Wong, Alan Chun Kit Lee, Clarence T T Wong

Förderung

  • Hong Kong Polytechnic University
  • Hong Kong Polytechnic University Startup Fund for New Recruits

Zitieren

APA

Pong, K. C. C., Lai, Y. S., Wong, R. C. H., Lee, A. C. K., Chow, S. C. T., Lam, J. C. W., Ho, H. P., & Wong, C. T. T. (2024). Automated Uniform Spheroid Generation Platform for High Throughput Drug Screening Process. Biosensors. https://doi.org/10.3390/bios14080392

Vancouver

Pong KCC, Lai YS, Wong RCH, Lee ACK, Chow SCT, Lam JCW, et al. Automated Uniform Spheroid Generation Platform for High Throughput Drug Screening Process. Biosensors. 2024. doi:10.3390/bios14080392

BibTeX
@article{Pong2024,
  author = {Pong, Kelvin C C and Lai, Yuen Sze and Wong, Roy Chi Hang and Lee, Alan Chun Kit and Chow, Sam C T and Lam, Jonathan C W and Ho, Ho Pui and Wong, Clarence T T},
  title = {Automated Uniform Spheroid Generation Platform for High Throughput Drug Screening Process},
  journal = {Biosensors},
  year = {2024},
  doi = {10.3390/bios14080392}
}
Kostenlos starten →